Nurse Practitioner · Detroit, MI
NPI
1063726867
Since 2010
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4160 John R St, Suite 917
Detroit, MI, 48201
Phone (313) 745-4525
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,624
257 services
Medicare patients, 2024
99
Average age 69
Drug cost, 2024
$3.8M
2,323 prescriptions
Company payments, 2025
$1,061
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle Bastien was code 99214 (office e&m - established), 112 times for 73 patients. In total Michelle Bastien billed 257 services in 5 codes, and Medicare paid $8,624.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 112 | 73 | $55.18 | $6,180 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 108 | 78 | $10.01 | $1,081 |
| 99213 Office E&M - Established | Office | 35 | 30 | $34.39 | $1,204 |
By year: 2022 $12K for 219 services; 2023 $22K for 1,725 services; 2024 $8,624 for 257 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michelle Bastien prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 483 prescriptions and refills. In total Michelle Bastien wrote 2,323 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 483 | 1,083 | 150 | $18K |
| Prednisone Generic | 360 | 570 | 159 | $2,451 |
| Leflunomide Generic | 222 | 427 | 63 | $13K |
| Hydroxychloroquine Sulfate Generic | 149 | 335 | 46 | $8,815 |
| Allopurinol Generic | 130 | 304 | 43 | $2,148 |
| Humira(Cf) Pen Adalimumab | 108 | 111 | 16 | $719K |
| Rinvoq Upadacitinib | 79 | 91 | 13 | $531K |
| Enbrel Sureclick Etanercept | 70 | 75 | 14 | $521K |
| Xeljanz Xr Tofacitinib Citrate | 67 | 69 | 12 | $373K |
| Folic Acid Generic | 58 | 169 | 21 | $501 |
| Sulfasalazine Generic | 58 | 104 | 14 | $1,907 |
| Humira Pen Adalimumab | 52 | 53 | Under 11 | $344K |
| Diclofenac Sodium Generic | 46 | 53 | 17 | $1,190 |
| Methylprednisolone Generic | 44 | 46 | 31 | $282 |
| Orencia Clickject Abatacept | 43 | 45 | Under 11 | $254K |
Brand drugs: - claims; generic drugs: 1,657 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle Bastien $1,061 ($1,061 in general payments such as food, travel and fees) from 2 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $1,013.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.